E Deschamps de Paillette - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1989

[Cicletanine administered with other antihypertensive agents]D Grimberg, T Tarrade, E Deschamps de Paillette

European Journal of Haematology|April 21, 1998

Circadian-based effects of AcSDKP, with or without rhG-CSF on hematologic toxicity of chemotherapy in miceX M Li, C Soulard, E Filipski, et al.

The Journal of General Virology|September 1, 1992

Polyadenylic:polyuridylic acid-induced protection of BALB/c mice against acute murine cytomegalovirus infectionA Adams, M Mohrman, A G Johnson, et al.

AIDS Research and Human Retroviruses|February 1, 1992

Antiviral action of polyadenylic-polyuridylic acid against HIV in cell culturesA G Laurent-Crawford, B Krust, E Deschamps de Paillette, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992

Polyadenylic: polyuridylic acid-induced determinants of host resistance to cytomegalovirus and their potentiation by hyperthermiaB K Lee, M Mohrman, M J Odean, et al.

Experimental Hematology|January 29, 1999

Chronopharmacologic aspects of continuous AcSDKP infusion in miceX M Li, E Ezan, G Bindoula, et al.

International Journal of Cancer|April 9, 1998

Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSFA E Bogden, J P Moreau, C Gamba-Vitalo, et al.

Klinische Wochenschrift|January 1, 1985

A classification of essential hypertensive patients according to the erythrocyte Na transport abnormalities: an application for monitoring the antihypertensive response to cicletanideR Garay, C Nazaret, P Hannaert, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994

Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesisE Ezan, P Carde, J Le Kerneau, et al.

Blood|January 15, 1998

The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitorsA Massé, L H Ramirez, G Bindoula, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1989

[Cicletanine administered with other antihypertensive agents]D Grimberg, T Tarrade, E Deschamps de Paillette

European Journal of Haematology|April 21, 1998

Circadian-based effects of AcSDKP, with or without rhG-CSF on hematologic toxicity of chemotherapy in miceX M Li, C Soulard, E Filipski, et al.

The Journal of General Virology|September 1, 1992

Polyadenylic:polyuridylic acid-induced protection of BALB/c mice against acute murine cytomegalovirus infectionA Adams, M Mohrman, A G Johnson, et al.

AIDS Research and Human Retroviruses|February 1, 1992

Antiviral action of polyadenylic-polyuridylic acid against HIV in cell culturesA G Laurent-Crawford, B Krust, E Deschamps de Paillette, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992

Polyadenylic: polyuridylic acid-induced determinants of host resistance to cytomegalovirus and their potentiation by hyperthermiaB K Lee, M Mohrman, M J Odean, et al.

Experimental Hematology|January 29, 1999

Chronopharmacologic aspects of continuous AcSDKP infusion in miceX M Li, E Ezan, G Bindoula, et al.

International Journal of Cancer|April 9, 1998

Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSFA E Bogden, J P Moreau, C Gamba-Vitalo, et al.

Klinische Wochenschrift|January 1, 1985

A classification of essential hypertensive patients according to the erythrocyte Na transport abnormalities: an application for monitoring the antihypertensive response to cicletanideR Garay, C Nazaret, P Hannaert, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994

Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesisE Ezan, P Carde, J Le Kerneau, et al.

Blood|January 15, 1998

The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitorsA Massé, L H Ramirez, G Bindoula, et al.

Pageof 2